NEWS

News and Insights

13 February, 2023

Valoe Has Agreed on 5,000,000€ Financial Arrangement with Winance.

Valoe Has Agreed on 5,000,000€ Financial Arrangement with Winance. Funding Will be Used as Working Capital after the Signing of .....Read More

Genomic Vision Announces New Financing Line with Winance, Subject to Prior Approval of the Company’s Shareholders

Bagneux (France) - Genomic Vision (FR0011799907 – GV – the “Company”), a biotechnology company that develops tools and s.....Read More

ISSUE OF THE FINAL CONVERTIBLE NOTES AND WARRANTS PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND WINANCE DISCLOSED ON 22 APRIL 2020.

Valoe Corporation has, pursuant to the terms and conditions of the financing arrangement between Valoe Corporation and W.....Read More

24 December, 2021

Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants for €2 million,

Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants (OCABSA) for €2 million, as p.....Read More

6 December, 2021

Zenith Energy Ltd is pleased to announce that it has entered into a supplementary loan agreement with Winance.

Zenith Energy Ltd. ("Zenith" or the "Company") (LSE: ZEN; OSE: ZENA), the Africa focused energy production and development compa.....Read More

GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS.

Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants (OCABSA) for €2 million, as p.....Read More

Zenith Energy Ltd, the listed international oil & gas production company focused on pursuing African development opportunities,

Zenith Energy Ltd. ("Zenith" or the "Company") , the listed international oil & gas production company focused on pu.....Read More

Genomic Vision Announces the Issuance of the 2nd Tranche of Convertible Notes

By using the delegation granted by the extraordinary shareholders meeting, Genomic Vision’s Executive Board opted, on March 1st,.....Read More

24 November, 2020

GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS

As part of the financing line concluded with Winance, Genomic Vision announces the issuance of the first tranche of convertible notes with warrants (OCABSA) for €0.8 million

10 August, 2020

GV ANNOUNCES THE APPROVAL OF ALL THE RESOLUTIONS RECOMMENDED BY THE MANAGEMENT BOARD

The meeting approved the setting up of a financing line with Winance, the Company’s financial partner, through a reserved issuance of convertible notes with warrants (OCABSA).

1 2 3 4 Next »